Guidance on new therapies in multiple sclerosis patients.
Gonsette
R E
RE
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000068717:Glatiramer Acetate; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000628:therapy*; D010455:Peptides / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
D000276:Adjuvants, Immunologic; D007166:Immunosuppressive Agents; D010455:Peptides; D000068717:Glatiramer Acetate; D016899:Interferon-beta